Cited by 796Signaling Pathways in DiseaseProtein Kinase Regulation and GTPase SignalingCancer-related Molecular Pathways

The DOI matches its Crossref record; 39 of the 42 references it cites were found in a registry or an index.

A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

Yeh, Elizabeth, Cunningham, Melissa, Arnold, Hugh, Chasse, Dawn, Monteith, Teresa, Ivaldi, Giovanni, Hahn, William C., Stukenberg, P. Todd, Shenolikar, Shirish, Uchida, Takafumi, Counter, Christopher M., Nevins, Joseph R., Means, Anthony R., Sears, Rosalie·2004·Nature Cell Biology

DOI 10.1038/ncb1110

Open this paper in CoChat — free account

Abstract

The stability of c-Myc is regulated by multiple Ras effector pathways. Phosphorylation at Ser 62 stabilizes c-Myc, whereas subsequent phosphorylation at Thr 58 is required for its degradation. Here we show that Ser 62 is dephosphorylated by protein phosphatase 2A (PP2A) before ubiquitination of c-Myc, and that PP2A activity is regulated by the Pin1 prolyl isomerase. Furthermore, the absence of Pin1 or inhibition of PP2A stabilizes c-Myc. A stable c-Myc(T58A) mutant that cannot bind Pin1 or be dephosphorylated by PP2A replaces SV40 small T antigen in human cell transformation and tumorigenesis assays. Therefore, small T antigen, which inactivates PP2A, exerts its oncogenic potential by preventing dephosphorylation of c-Myc, resulting in c-Myc stabilization. Thus, Ras-dependent signalling cascades ensure transient and self-limiting accumulation of c-Myc, disruption of which contributes to human cell oncogenesis.

Integrity signals

Registry

Crossref · 10.1038/ncb1110

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
A simplified system for generating recombinant adenoviruses
He, T., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,209
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M. W., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,941
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citation
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint
Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,411
Self-citation
MYC oncogenes and human neoplastic disease
Nesbit, C. E., Tersak, J. M., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202746 · Cited by 1,163
Teratocarcinomas and Embryonic Stem Cells: A Practical Approach
Robertson, E. J., & Beddington, R. (1988) · Development · doi:10.1242/dev.102.1.3 · Cited by 1,034
Teratocarcinomas and embryonic stem cells: A practical approach
Krumlauf, R. K. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90286-1 · Cited by 779
THE myc ONCOGENE: ITS ROLE IN TRANSFORMATION AND DIFFERENTIATION
Cole, M. D. (1986) · Annual Review of Genetics · doi:10.1146/annurev.ge.20.120186.002045 · Cited by 699
Function of WW Domains as Phosphoserine- or Phosphothreonine-Binding Modules
Lu, P., Zhou, X. Z., Shen, M., & Lu, K. P. (1999) · Science · doi:10.1126/science.283.5406.1325 · Cited by 688

Flagged first, then by citations

Show all 42 references

3 of the 42 references couldn’t be matched to a known paper.

Sorted by citations

Items 401–500 of 796

The role of exosomes and MYC in therapy resistance of acute myeloid leukemia: Challenges and opportunities
Mudgapalli, N., Nallasamy, P., Chava, H., Chava, S. P., Pathania, A. S., Gunda, V., Gorantla, S., Pandey, M. K., Gupta, S. C., & Challagundla, K. B. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.10.001 · Cited by 31
Nuclear import of Pin1 is mediated by a novel sequence in the PPIase domain
Lufei, C., & Cao, X. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.12.011 · Cited by 32
Pin1-dependent Prolyl Isomerization Modulates the Stress-induced Phosphorylation of High Molecular Weight Neurofilament Protein
Rudrabhatla, P., Zheng, Y., Amin, N. D., Kesavapany, S., Albers, W., & Pant, H. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801633200 · Cited by 32
Growing and dividing: how O-GlcNAcylation leads the way
Saunders, H. I., Dias, W. B., & Slawson, C. M. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105330 · Cited by 30
Anti‐proliferative effects of γ‐tocotrienol are associated with suppression of c‐Myc expression in mammary tumour cells
Parajuli, P., Tiwari, R., & Sylvester, P. W. (2015) · Cell Proliferation · doi:10.1111/cpr.12196 · Cited by 30
Inhibition of Plk1 and Pin1 by 5′-nitro-indirubinoxime suppresses human lung cancer cells
Yoon, H., Kim, S., Choi, H.-S., Ahn, M., Yoon, J., & Ahn, S. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.029 · Cited by 31
Characterization of ARF-BP1/HUWE1 Interactions with CTCF, MYC, ARF and p53 in MYC-Driven B Cell Neoplasms
Qi, C., Kim, Y., Shao, X., Abdullaev, Z., Torrey, T. A., Janz, S., Kovalchuk, A. L., Sun, J., Chen, D., Cho, W. C. S., et al. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13056204 · Cited by 31
In vitro evaluation of the antioxidant and cytotoxic activities of constituents of the mangrove Lumnitzera racemosa Willd.
Thảo, N. P., Luyen, B. T. T., Điệp, C. N., Tài, B. H., Kim, E. J., Kang, H. K., Lee, S. H., Jang, H. D., Cuong, N. T., Thành, N. V., et al. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0429-y · Cited by 30
Novel ubiquitin-independent nucleolar c-Myc degradation pathway mediated by antizyme 2
Murai, N., Murakami, Y., Tajima, A., & Matsufuji, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-21189-0 · Cited by 30
Drug Screening with Genetically Encoded Fluorescent Sensors: Today and Tomorrow
Potekhina, E. S., Bass, D. Y., Kelmanson, I. V., Fetisova, E. S., Ivanenko, A. V., Belousov, V. V., & Bilan, D. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010148 · Cited by 29
8q24.21 Locus: A Paradigm to Link Non-Coding RNAs, Genome Polymorphisms and Cancer
Wilson, C., & Kanhere, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031094 · Cited by 30
PPP6C negatively regulates oncogenic ERK signaling through dephosphorylation of MEK
Cho, E., Lou, H. J., Kuruvilla, L., Calderwood, D., & Turk, B. E. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108928 · Cited by 30
PINning down the c-Myc oncoprotein
Dominguez-Sola, D., & Dalla‐Favera, R. (2004) · Nature Cell Biology · doi:10.1038/ncb0404-288 · Cited by 30
Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE
Pütz, S. M., Vogiatzi, F., Stiewe, T., & Sickmann, A. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-254 · Cited by 29
Posttranslational Modifications of Defined Embryonic Reprogramming Transcription Factors
Ramakrishna, S., Kim, K., & Baek, K. (2014) · Cellular Reprogramming · doi:10.1089/cell.2013.0077 · Cited by 30
PP2A-activating Drugs Enhance FLT3 Inhibitor Efficacy through AKT Inhibition–Dependent GSK-3β–Mediated c-Myc and Pim-1 Proteasomal Degradation
Scarpa, M., Singh, P., Bailey, C. M., Lee, J. K., Kapoor, S., Lapidus, R. G., Niyongere, S., Sangodkar, J., Wang, Y., Perrotti, D., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0663 · Cited by 30
From the Evasion of Degradation to Ubiquitin-Dependent Protein Stabilization
Ahmad, Y. A., Oknin-Vaisman, A., Bitman-Lotan, E., & Orian, A. (2021) · Cells · doi:10.3390/cells10092374 · Cited by 26
The long noncoding RNA regulation at the MYC locus
Xiang, J., Yang, L. C., & Chen, L. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.07.001 · Cited by 29
New Functions for PI3K in the Control of Cell Division
Kumar, A., & Carrera, A. C. (2007) · Cell Cycle · doi:10.4161/cc.6.14.4492 · Cited by 29
Understanding transformation: progress and gaps
Boehm, J. S., & Hahn, W. C. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.11.003 · Cited by 31
Self-citation
Microcystin-LR stabilizes c-myc protein by inhibiting protein phosphatase 2A in HEK293 cells
Fan, H., Cai, Y., Xie, P., Xiao, W., Chen, J., Ji, W., & Zhao, S. (2014) · Toxicology · doi:10.1016/j.tox.2014.02.015 · Cited by 29
iTRAQ Analysis of a Cell Culture Model for Malignant Transformation, Including Comparison with 2D-PAGE and SILAC
Pütz, S. M., Boehm, A., Stiewe, T., & Sickmann, A. (2012) · Journal of Proteome Research · doi:10.1021/pr200881c · Cited by 28
Lysine 394 is a novel Rad6B-induced ubiquitination site on beta-catenin
Gérard, B., Sanders, M. A., Visscher, D. W., Tait, L. R., & Shekhar, M. P. V. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.032 · Cited by 28
Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant
Thibodeaux, C. A., Liu, X., Disbrow, G. L., Zhang, Y., Rone, J. D., Haddad, B. R., & Schlegel, R. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0127-x · Cited by 28
Dual regulation of Myc by Abl
Lobo, V. J. S.-A., Doni, M., Verrecchia, A., Sanulli, S., Fagà, G., Piontini, A., Bianchi, M., Conacci‐Sorrell, M., Mazzarol, G., Peg, V., et al. (2013) · Oncogene · doi:10.1038/onc.2012.621 · Cited by 28
Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer
Ueda, M., Iguchi, T., Nambara, S., Saito, T., Komatsu, H., Sakimura, S., Hirata, H., Uchi, R., Takano, Y., Shinden, Y., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4652-7 · Cited by 28
Development of Pin1 Inhibitors and their Potential as Therapeutic Agents
Nakatsu, Y., Matsunaga, Y., Ueda, K., Yamamotoya, T., Inoue, Y., Inoue, M.-K., Mizuno, Y., Kushiyama, A., Ono, H., Fujishiro, M., et al. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181105120911 · Cited by 26
KeePin’ the p53 Family in Good Shape
Mantovani, F., Gostissa, M., Collavin, L., & Sal, G. D. (2004) · Cell Cycle · doi:10.4161/cc.3.7.999 · Cited by 28
Myc stabilization in response to estrogen and phospholipase D in MCF‐7 breast cancer cells
Rodrik-Outmezguine, V. S., Gomes, E., Li, H., Rockwell, P., & Foster, D. A. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.09.013 · Cited by 28
Unraveling MYC’s Role in Orchestrating Tumor Intrinsic and Tumor Microenvironment Interactions Driving Tumorigenesis and Drug Resistance
Doha, Z. O., & Sears, R. C. (2023) · Pathophysiology · doi:10.3390/pathophysiology30030031 · Cited by 27
Self-citation
CIP2A expression is elevated in cervical cancer
Huang, L. P., Adelson, M. E., Mordechai, E., & Trama, J. P. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0220 · Cited by 27
Asterosaponins from the Starfish Astropecten monacanthus Suppress Growth and Induce Apoptosis in HL-60, PC-3, and SNU-C5 Human Cancer Cell Lines
Thảo, N. P., Luyen, B. T. T., Kim, E., Kang, H., Kim, S., Cường, N. X., Nam, N. H., Kiệm, P. V., Minh, C. V., & Kim, Y. H. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00705 · Cited by 27
Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer.
Arapshian, A., Bertran, S., Kuppumbatti, Y. S., Nakajo, S., & Mira-y-Lopez, R. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-13 · Cited by 27
SCFFBXW7α modulates the intra-S-phase DNA-damage checkpoint by regulating Polo like kinase-1 stability
Giráldez, S., Herrero‐Ruiz, J., Mora‐Santos, M., Japón, M. Á., Tortolero, M., & Romero, F. (2014) · Oncotarget · doi:10.18632/oncotarget.2021 · Cited by 26
Akt Increases Sox2 Expression in Adult Hippocampal Neural Progenitor Cells, but Increased Sox2 Does Not Promote Proliferation
Peltier, J., Conway, A., Keung, A. J., & Schaffer, D. V. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0130 · Cited by 27
Myc cooperates with beta-catenin to drive gene expression in the nephron progenitor cells
Pan, X., Karner, C. M., & Carroll, T. J. (2017) · Development · doi:10.1242/dev.153700 · Cited by 27
Romo1 is a negative-feedback regulator of Myc
Lee, S. B., Kim, J. J., Chung, J. S., Lee, M.-S., Lee, K.-H., Kim, B. S., & Yoo, Y. D. (2011) · Journal of Cell Science · doi:10.1242/jcs.079996 · Cited by 27
Regulation mechanism of Fbxw7-related signaling pathways (Review)
Zhou, Z., He, C., & Wang, J. (2015) · Oncology Reports · doi:10.3892/or.2015.4227 · Cited by 25
PP2A Counterbalances Phosphorylation of pRB and Mitotic Proteins by Multiple CDKs: Potential Implications for PP2A Disruption in Cancer
Kurimchak, A., & Graña, X. (2012) · Genes & Cancer · doi:10.1177/1947601912473479 · Cited by 29
Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells
Darr, J., Klochendler, A., Isaac, S., Geiger, T., & Eden, A. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0439-5 · Cited by 26
Peroxynitrite promotes serine-62 phosphorylation-dependent stabilization of the oncoprotein c-Myc
Raman, D., Chong, S. J. F., Iskandar, K. B., Hirpara, J. L., & Pervaiz, S. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101587 · Cited by 25
The Molecular ‘Myc-anisms’ behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
McAnulty, J., & DiFeo, A. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249486 · Cited by 28
Cardamonin inhibits the growth of human osteosarcoma cells through activating P38 and JNK signaling pathway
Zhang, L., Yang, C., Huang, Y., Huang, H., Yuan, X., Zhang, P., Ye, C., Wei, M., Wang, Y., Luo, X., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111155 · Cited by 26
Alkaline phosphatase downregulation promotes lung adenocarcinoma metastasis via the c-Myc/RhoA axis
Lou, Z., Lin, W., Zhao, H., Jiao, X., Wang, C., Zhao, H., Liu, L., Liu, Y., Xie, Q., Huang, X., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01919-7 · Cited by 26
MYC in T-cell acute lymphoblastic leukemia: functional implications and targeted strategies
Li, Q., Pan, S., Xie, T., & Liu, H. (2021) · Blood Science · doi:10.1097/bs9.0000000000000073 · Cited by 26
Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia
Chen, L., Sun, Y., Wang, J.-Y., Jiang, H., & Muntean, A. G. (2016) · OncoTarget · doi:10.18632/oncotarget.8199 · Cited by 27
Concerted Action of PGC-1-related Coactivator (PRC) and c-MYC in the Stress Response to Mitochondrial Dysfunction
Gleyzer, N., & Scarpulla, R. C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719682 · Cited by 26
Regulation of Transcription Factor Function by Targeted Protein Degradation: An Overview Focusing on p53, c-Myc, and c-Jun
Westermarck, J. K. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-738-9_2 · Cited by 28
Adenovirus E4orf4 Protein DownregulatesMYCExpression through Interaction with the PP2A-B55 Subunit
Ben-Israel, H., Sharf, R., Rechavi, G., & Kleinberger, T. (2008) · Journal of Virology · doi:10.1128/jvi.00791-08 · Cited by 26
The Drosophila F-box protein Archipelago controls levels of the Trachealess transcription factor in the embryonic tracheal system
Mortimer, N. T., & Moberg, K. H. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.10.002 · Cited by 27
Protein Never in Mitosis Gene A Interacting-1 (PIN1) regulates degradation of inducible nitric oxide synthase in endothelial cells
Liu, T., Huang, Y., Likhotvorik, R. I., Keshvara, L., & Hoyt, D. G. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00366.2007 · Cited by 25
FRA1 is a determinant for the difference in RAS-induced transformation between human and rat fibroblasts
Kakumoto, K., Sasai, K., Sukezane, T., Oneyama, C., Ishimaru, S., Shibutani, K., Mizushima, H., Mekada, E., Hanafusa, H., & Akagi, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601222103 · Cited by 25
Optimal Suppression of Protein Phosphatase 2A Activity Is Critical for Maintenance of Human Embryonic Stem Cell Self-Renewal
Yoon, B. S., Jun, E. K., Park, G., Yoo, S. J., Moon, J.-H., Baik, C. S., Kim, A., Kim, H., Kim, J., Koh, G. Y., et al. (2010) · Stem Cells · doi:10.1002/stem.412 · Cited by 25
The Popeye domain containing gene family encoding a family of cAMP-effector proteins with important functions in striated muscle and beyond
Swan, A. H., Gruscheski, L., Boland, L. A., & Brand, T. (2019) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-019-09523-z · Cited by 23
The role of aurora A and polo-like kinases in high-risk lymphomas
Murga‐Zamalloa, C., Inamdar, K. V., & Wilcox, R. A. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000232 · Cited by 24
Targeting the EphB4 receptor tyrosine kinase sensitizes HER2-positive breast cancer cells to Lapatinib
Ding, J., Yao, Y., Huang, G., Wang, X., Yi, J., Zhang, N., Liu, C., Wang, K., Zhang, Y., Wang, M., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.032 · Cited by 26
RhoB facilitates c-Myc turnover by supporting efficient nuclear accumulation of GSK-3
Huang, M., Kamasani, U. R., & Prendergast, G. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209174 · Cited by 25
Understanding the role of PIN1 in hepatocellular carcinoma
Cheng, C.-W., Leong, K.-W., & Tse, E. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i45.9921 · Cited by 24
Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease
Zhang, D., Damoiseaux, R. D., Babayan, L., Rivera-Meza, E. K., Yang, Y., Bergsneider, M., Wang, M. B., Yong, W. H., Kelly, K. A., & Heaney, A. P. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa699 · Cited by 24
The roles of peptidyl-proline isomerases in gene regulation1This review is part of Special Issue entitled Asilomar Chromatin and has undergone the Journal’s usual peer review process.
Dilworth, D., Gudavicius, G., Leung, A., & Nelson, C. J. (2012) · Biochemistry and Cell Biology · doi:10.1139/o11-045 · Cited by 25
Irs2 Inactivation Suppresses Tumor Progression in Pten+/− Mice
Szabolcs, M. J., Keniry, M. E., Simpson, L., Reid, L. J., Koujak, S., Schiff, S. C., Davidian, G., Licata, S. E., Gruvberger-Saal, S. K., Murty, V. V. V. S., et al. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080086 · Cited by 24
Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation
Iriyama, N., Yuan, B., Hatta, Y., Takagi, N., & Takei, M. (2016) · Cancer Cell International · doi:10.1186/s12935-016-0314-5 · Cited by 24
Steroidal Constituents from the Edible Sea Urchin Diadema savignyi Michelin Induce Apoptosis in Human Cancer Cells
Thảo, N. P., Luyen, B. T. T., Kim, E. J., Kang, J. I., Kang, H. K., Cường, N. X., Nam, N. H., Kiệm, P. V., Minh, C. V., & Kim, Y. H. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2013.3105 · Cited by 24
TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells
Whillock, A. L., Mambetsariev, N., Lin, W., Stunz, L. L., & Bishop, G. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-49390-9 · Cited by 23
Histone‐lysine N‐methyltransferase EHMT2 (G9a) inhibition mitigates tumorigenicity in Myc‐driven liver cancer
Thng, D. K. H., Hooi, L., Toh, C. C. M., Lim, J. J., Rajagopalan, D., Syariff, I. Q. C., Tan, Z. M., Rashid, M. B. M. A., Zhou, L., Kow, A. W. C., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13417 · Cited by 23
A Guide to PIN1 Function and Mutations Across Cancers
Boustani, M. E., Stefano, L. D., Caligiuri, I., Mouawad, N., Granchi, C., Canzonieri, V., Tuccinardi, T., Giordano, A., & Rizzolio, F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01477 · Cited by 23
Post-translational Modifications of the Peptidyl-Prolyl Isomerase Pin1
Chen, D., Wang, L., & Lee, T. H. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00129 · Cited by 23
AS101 Prevents Diabetic Nephropathy Progression and Mesangial Cell Dysfunction: Regulation of the AKT Downstream Pathway
Shemesh, I. I., Rozen‐Zvi, B., Kalechman, Y., Gafter, U., & Sredni, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114287 · Cited by 23
Understanding the regulatory landscape of protein phosphatase 2A (PP2A): Pharmacological modulators and potential therapeutics
Neale, D. B., Morris, J. C., Verrills, N. M., & Ammit, A. J. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108834 · Cited by 25
Disarming mutant p53 oncogenic function
Girardini, J. E., Marotta, C., & Sal, G. D. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.003 · Cited by 23
Enhancement of c-Myc degradation by Bloom (BLM) helicase leads to delayed tumor initiation
Chandra, S., Priyadarshini, R., Madhavan, V., Tikoo, S., Hussain, M., Mudgal, R., Modi, P., Srivastava, V. K., & Sengupta, S. (2013) · Journal of Cell Science · doi:10.1242/jcs.124719 · Cited by 22
Inositol pyrophosphates promote MYC polyubiquitination by FBW7 to regulate cell survival
Lolla, P., Shah, A., Unnikannan, C. P., Oddi, V., & Bhandari, R. (2021) · Biochemical Journal · doi:10.1042/bcj20210081 · Cited by 21
Phosphorylation regulates Myc expression via prolonged activation of the mitogen‐activated protein kinase pathway
Wang, Z., Ge, L., Wang, M., & Carr, B. I. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20649 · Cited by 22
Suppression of c-Myc induces apoptosis via an AMPK/mTOR-dependent pathway by 4-O-methyl-ascochlorin in leukemia cells
Shin, J.-M., Jeong, Y., Cho, H.-J., Magae, J., Bae, Y., & Chang, Y. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1228-3 · Cited by 22
Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer
Choi, C. H., Chung, J., Kang, J. H., Paik, E. S., Lee, Y.-Y., Park, W., Byeon, S., Chung, E. J., Kim, B., Hewitt, S. M., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.02.017 · Cited by 21
PIM3 Kinase: A Promising Novel Target in Solid Cancers
Atalay, P., & Özpolat, B. (2024) · Cancers · doi:10.3390/cancers16030535 · Cited by 20
PIN1 Provides Dynamic Control of MYC in Response to Extrinsic Signals
Cohn, G., Liefwalker, D. F., Langer, E. M., & Sears, R. C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00224 · Cited by 20
Self-citation
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
Bownes, L. V., Marayati, R., Quinn, C. H., Beierle, A. M., Hutchins, S. C., Julson, J. R., Erwin, M. H., Stewart, J. E., Mroczek‐Musulman, E., Ohlmeyer, M. H. J., et al. (2022) · Cancers · doi:10.3390/cancers14081952 · Cited by 21
Ubiquitination of Myc: Proteasomal Degradation and Beyond
Müller, J., & Eilers, M. (2008) · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings · doi:10.1007/2789_2008_103 · Cited by 20
Potential role of CARMA1 in CD40‐induced splenic B cell proliferation and marginal zone B cell maturation
Pappu, B. P., & Lin, X. (2006) · European Journal of Immunology · doi:10.1002/eji.200535663 · Cited by 20
Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma
Teng, B. L., Hacker, K. E., Chen, S., Means, A. R., & Rathmell, W. K. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.06.002 · Cited by 20
Self-citation
PP2A-B55β Antagonizes Cyclin E1 Proteolysis and Promotes Its Dysregulation in Cancer
Tan, Y., Sun, D., Jiang, W., Klotz‐Noack, K., Vashisht, A. A., Wohlschlegel, J. A., Widschwendter, M., & Spruck, C. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1263 · Cited by 20
Controlling the Master: Chromatin Dynamics at the MYC Promoter Integrate Developmental Signaling
Zaytseva, O., & Quinn, L. M. (2017) · Genes · doi:10.3390/genes8040118 · Cited by 20
Dynamic regulation of Pin1 expression and function during zebrafish development
Ibarra, M. S., Etichetti, C. B., Benedetto, C. D., Rosano, G. L., Margarit, E., Sal, G. D., Mione, M., & Girardini, J. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175939 · Cited by 20
Oncoprotein stabilization in brain tumors
Hede, S.-M., Savov, V., Weishaupt, H., Sangfelt, O., & Swartling, F. J. (2013) · Oncogene · doi:10.1038/onc.2013.445 · Cited by 20
Immortalized cells as experimental models to study cancer
Boehm, J. S., & Hahn, W. C. (2004) · Cytotechnology · doi:10.1007/s10616-004-5125-1 · Cited by 22
Self-citation
Design, synthesis and evaluation of novel indole derivatives as AKT inhibitors
Yang, D., Wang, P., Liu, J., Xing, H., Liu, Y., Xie, W., & Zhao, G. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.11.022 · Cited by 20
The peptidyl prolyl cis/trans isomerase Pin1 downregulates the Inhibitor of Apoptosis Protein Survivin
Dourlen, P., Ando, K., Hamdane, M., Bégard, S., Buée, L., & Galas, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.05.012 · Cited by 20
ALDOC promotes neuroblastoma progression and modulates sensitivity to chemotherapy drugs by enhancing aerobic glycolysis
Chen, Y., Zhu, H., Luo, Y., Xie, T., Hu, Y., Yan, Z., Ji, W., Wang, Y., Yin, Q., & Xian, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1573815 · Cited by 19
EST12 regulates Myc expression and enhances anti-mycobacterial inflammatory response via RACK1-JNK-AP1-Myc immune pathway
Wu, J., Luo, F., Xie, Y., Xiong, H., Gao, Y., Liu, G., & Zhang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.943174 · Cited by 19
Small molecules targeting Pin1 as potent anticancer drugs
Zhang, J., Zhou, W., Chen, Y., Wang, Y., Guo, Z., Hu, W., Li, Y., Han, X., & Si, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1073037 · Cited by 19
A Novel Synthesis of Highly Substituted Perhydropyrrolizines, Perhydroindolizines, and Pyrrolidines: Inhibition of the Peptidyl‐Prolyl cis/trans Isomerase (PPIase) Pin1
Siegrist, R., Zürcher, M., Baumgartner, C., Seiler, P., Diederich, F., Daum, S., Fischer, G. S., Klein, C., Dangl, M., & Schwaiger, M. (2007) · Helvetica Chimica Acta · doi:10.1002/hlca.200790028 · Cited by 19
Implications of Functional Proteomics in Breast Cancer
Chae, Y. K., & Gonzalez-Angulo, A. M. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0437 · Cited by 19
c-MYC amplification in mucinous gastric carcinoma: a possible genetic alteration leading to deeply invasive tumors.
Choi, J., Seo, J., Jung, E. J., Kim, E. J., Lee, G. K., & Kim, W. H. (2012) · PubMed · Cited by 19
Exploring MYC relevance to cancer biology from the perspective of cell competition
Paglia, S., Sollazzo, M., Giacomo, S. D., Strocchi, S., & Grifoni, D. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.009 · Cited by 18
Pinning Down the Transcription: A Role for Peptidyl-Prolyl cis-trans Isomerase Pin1 in Gene Expression
Hu, X., & Chen, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00179 · Cited by 19
Long non‑coding RNAs in prostate tumorigenesis and therapy (Review)
Jiang, G., SU, Z., Liang, X., Huang, Y., Lan, Z., & Jiang, X. (2020) · Molecular and Clinical Oncology · doi:10.3892/mco.2020.2146 · Cited by 19
Peptidyl‐prolyl cis‐trans isomerase NIMA‐interacting 1 directly binds and stabilizes Nrf2 in breast cancer
Saeidi, S., Kim, S., Quispe, Y. N. G., Jagadeesh, A., Han, H., Kim, S. H., Zhong, X., Piao, J., Kim, S., Jeong, J., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100776rr · Cited by 19
FBW7-mediated ubiquitination and degradation of KLF5
Luan, Y. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i2.216 · Cited by 19
Ionic Currents of Human Trabecular Meshwork Cells from Control and Glaucoma Subjects
Grant, J., Tran, V., Bhattacharya, S. K., & Bianchi, L. K. (2012) · The Journal of Membrane Biology · doi:10.1007/s00232-012-9517-4 · Cited by 19

Authors: Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W. C., Stukenberg, P. T., Shenolikar, S., Uchida, T., Counter, C. M., Nevins, J. R., Means, A. R., & Sears, R.
Affiliations: Duke Medical Center (US)
Oregon Health & Science University (US)
Howard Hughes Medical Institute (US)
Duke University (US)
Brigham and Women's Hospital (US)
University of Virginia (US)
Tohoku University (JP)
Corresponding author: Sears, Rosalie
ORCID: Yeh, Elizabeth
Chasse, Dawn
Hahn, William C.
Stukenberg, P. Todd
Shenolikar, Shirish
Uchida, Takafumi
Counter, Christopher M.
Means, Anthony R.
Sears, Rosalie
Venue: Nature Cell Biology
Publisher: Springer Science and Business Media LLC
Published: 2004-03-14
Volume: 6
Issue: 4
Pages: 308-318
ISSN: 1465-7392 (ISSN-L)
1476-4679
DOI: 10.1038/ncb1110
OpenAlex: W2105214585
Cited by: 791
References: 42
Citations by year: 2026: 10 · 2025: 25 · 2024: 27 · 2023: 29 · 2022: 24 · 2021: 40 · 2020: 42 · 2019: 33 · 2018: 30 · 2017: 32 · 2016: 37 · 2015: 39 · 2014: 53 · 2013: 39 · 2012: 31
FWCI: 16.61
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Cell Biology (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
National Cancer Institute (K01CA086957, CA 100855, R01CA082845, CA 86957, CA 82845, R01CA100855)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: c-Myc, protein stability, protein phosphatase 2A, ubiquitination, Ras signaling, oncogenic transformation, SV40 small t antigen, carcinogenesis
MeSH terms: NIMA-Interacting Peptidylprolyl Isomerase, Amino Acid Sequence, Animals, Antigens, Polyomavirus Transforming, Cell Line, Cell Transformation, Neoplastic, Humans, Mutation, Neoplasms, Phosphoprotein Phosphatases, Phosphorylation, Serine, Threonine, Signal Transduction, Genes, myc, Proto-Oncogene Proteins c-myc, Peptidylprolyl Isomerase, RNA Stability, Mice, Rats, Protein Phosphatase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks